1. Home
  2. PTCT vs TFX Comparison

PTCT vs TFX Comparison

Compare PTCT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$71.41

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$139.74

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
TFX
Founded
1998
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.8B
IPO Year
2006
1994

Fundamental Metrics

Financial Performance
Metric
PTCT
TFX
Price
$71.41
$139.74
Analyst Decision
Buy
Buy
Analyst Count
17
8
Target Price
$80.65
$138.75
AVG Volume (30 Days)
794.0K
570.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
1.02%
EPS Growth
264.48
N/A
EPS
0.90
2.08
Revenue
$264,734,000.00
$1,992,713,000.00
Revenue This Year
N/A
$15.97
Revenue Next Year
$17.70
$5.15
P/E Ratio
$79.77
$67.77
Revenue Growth
36.19
N/A
52 Week Low
$57.08
$100.18
52 Week High
$90.87
$145.00

Technical Indicators

Market Signals
Indicator
PTCT
TFX
Relative Strength Index (RSI) 45.98 55.17
Support Level $67.57 $128.36
Resistance Level $73.86 $145.00
Average True Range (ATR) 2.00 4.12
MACD 0.17 0.23
Stochastic Oscillator 54.41 66.50

Price Performance

Historical Comparison
PTCT
TFX

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About TFX Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Share on Social Networks: